ETTX
Entasis Therapeutics Holdings Inc.
No insider bought or sold Entasis Therapeutics Holdings Inc. in the last 12 months
ETTX over the last year
Prices for ETTX aren't in yet.
ETTX after insider buys
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Every filing
15 insider filings since 2018, newest first
Innoviva, Inc. · 10% owner
Manoussos Perros · Insider
Innoviva, Inc. · 10% owner
Innoviva, Inc. · 10% owner
Frazier Life Sciences Viii, L.P. · 10% owner
Astrazeneca Plc · 10% owner
James N Topper · Director and 10% owner
Sofinnova Venture Partners Ix, L.P. · 10% owner
Heather Preston · Director and 10% owner
Pivotal Bioventure Partners Fund I, L.P. · 10% owner
Nicholas Galakatos · Director and 10% owner
Frazier Life Sciences Viii, L.P. · 10% owner
Tpg Group Holdings (Sbs) Advisors, Inc. · Former 10% Owner
Clarus Lifesciences Iii, L.P. · 10% owner
Novo Holdings A/s · 10% owner
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.